Metrics as of 10/13/2026, 06:43 PM (Berlin time), refresh in progress.
Xtant Medical Holdings Stock
Xtant Medical Holdings, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Sean E. Browne
- Employees
- 151
- Market cap
- $45 M
- IPO
- 01/07/2010
Xtant Medical Holdings, Inc., a company based in Belgrade, Montana, specializes in the development, production, and distribution of advanced regenerative medicine products and medical devices. The firm primarily serves orthopedic and neurological surgeons both within the United States and globally. Its comprehensive…
Xtant Medical Holdings stock: price history
1D
-1.4%
1W
+1.1%
1M
-6.2%
6M
-36.4%
YTD
-58.6%
1Y
-59.5%
2Y
-46.1%
5Y
-71.6%
10Y
-97.3%
Next earnings date
Next earnings date
10/11/2026 (in 24 days)
Volatility around earnings
~55% stronger price swings than usual
Ask the agents about Xtant Medical Holdings
Analyst assessment of Xtant Medical Holdings
PRICE TARGET LOW
US$1.00
CONSENSUS
US$1.00
MEDIAN
US$1.00
PRICE TARGET HIGH
US$1.00
0
STRONG BUY
4
BUY
1
HOLD
0
SELL
0
STRONG SELL
5
TOTAL · Buy
As of: 13/05/2026
Xtant Medical Holdings stock metrics
P/E
-3.94
P/B
1.14
EV/EBITDA
-25.11
RETURN ON EQUITY
-23.5%
NET MARGIN
-40.9%
DEBT/EQUITY
0.65
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
86.2%
FLOAT SHARES
120,850,741
AVG. DAILY VOLUME (30D)
549,951
Insider transactions (SEC)
BAKEWELL JOHN K
Lipschultz Tyler
Vizirgianakis Stavros G.
Browne Sean E
Browne Sean E
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Xtant Medical Holdings stock
What does Xtant Medical Holdings do?
Xtant Medical Holdings, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Sean E. Browne, the company employs around 151 people.
The IPO was on 01/07/2010; the stock trades on AMEX under the ticker XTNT.
What do analysts say about Xtant Medical Holdings stock?
5 analysts rate the stock, the consensus is Buy (as of 13/05/2026).
The average price target is US$1.00, ranging from US$1.00 to US$1.00, with a median of US$1.00.
This is an external assessment, not a statement by Market Jury.
When does Xtant Medical Holdings report next?
The next earnings date is 10/11/2026.
Around past earnings, price swings were roughly 55% stronger than usual.
Does Xtant Medical Holdings pay a dividend?
No, Xtant Medical Holdings currently does not pay a dividend.
Which stocks are comparable to Xtant Medical Holdings?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Xtant Medical Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess Xtant Medical Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.